Cerecin CEO Dr. Charles Stacey Shares Insights on Ketones at TEDxNTU Talk

Cerecin Inc., a pioneering biotechnology firm dedicated to developing metabolic treatments for neurological issues, has announced that a pivotal TEDx talk delivered by their CEO, Dr. Charles Stacey, is now available for the public to view online. The talk, which took place at TEDxNTU in Singapore in October 2025, focuses on the groundbreaking concepts surrounding fasting, diet, and their implications for future medical practices, particularly in the realm of brain health.

Exploring the Power of Ketones

In the talk titled "The Potential of Fasting and Diet in the Future of Medicine," Dr. Stacey delves into the complex science behind brain energy metabolism. He highlights that the human brain, despite constituting only about 2% of total body weight, utilizes approximately 20% of the body's energy reserves. This significant demand for energy makes the brain particularly susceptible to energy shortages, which can contribute to a variety of neurological disorders.

Dr. Stacey emphasizes that when glucose levels in the body decline, an alternative energy source in the form of ketones, produced through fasting or a ketogenic diet, becomes vital. Ketones can efficiently cross the blood-brain barrier and serve as an energy fuel, supporting brain function during states of metabolic distress. He articulates, “If a failing brain is at its core an under-fueled brain, perhaps the solution lies in supplying it with more energy—not simply through increasing glucose levels, but by enhancing brain bioenergetics.”

Ketones and Neurological Health

In his insightful address, Dr. Stacey also references historical data and medical accounts linking fasting and ketogenic diets to improved seizure control, which ultimately led to the establishment of the modern ketogenic lifestyle. Furthermore, he illustrates how Cerecin, at the forefront of neuropharmaceutical innovation, is actively engaged in developing oral medications that deliver the benefits of ketosis without requiring strict dietary limitations.

Cerecin's promising pipeline includes drug candidates such as CER-0001 (tricaprilin) and CER-081, which have shown potential in clinical trials targeting conditions like Alzheimer's disease and rare pediatric epilepsies. Dr. Samuel Henderson, Cerecin's Chief Scientific Officer, underscores the organization's commitment to advancing the understanding of energy as a fundamental driver of brain functionality.

A Vision for the Future

By sharing his perspectives in this accessible format, Dr. Stacey aims to foster an informed discussion on the metabolic therapies that could address significant gaps in treating neurological diseases. His work emphasizes a transformative approach to brain health, utilizing insights from fasting and metabolism to inform the development of innovative therapeutic solutions.

As the TEDx talk illustrates, this evolving understanding of the brain’s energy needs presents an exciting frontier in medical science. The insights shared by Dr. Stacey not only highlight the potential of ketones as a metabolic treatment but also encourage a broader dialogue on nutritional strategies that could complement existing healthcare practices.

To view Dr. Charles Stacey’s TEDx talk, visit this link. It serves as an essential resource for those interested in the intersection of diet and neurological health, providing an optimistic perspective on the future of brain medicine.

Conclusion

Cerecin continues its mission to improve brain health through rigorous scientific inquiry and innovative product development, blending technology with the intricacies of human biology. As the company advances its research, it remains dedicated to unlocking new treatments that could one day transform the standard of care for individuals battling neurological disorders. Dr. Stacey's TEDx talk embodies Cerecin's commitment to bridging the gap between complex medical science and actionable health strategies, showcasing the immense potential that lies within the intersection of fasting, diet, and neurological healing.